Non-Executive Chairman, ICON plc
Expertise: Corporate Spokesperson and Industry Expert
Commentator on ICON and the general CRO Industry. Ciaran Murray is the Non-Executive Chairman of ICON plc since May 2018, having previously served as Executive Chairman from March 2017 to May 2018 and as Chief Executive Officer from October 2011 to March 2017. He joined ICON as Chief Financial Officer in 2005 and served in that capacity until his appointment as Chief Executive Officer in 2011. Ciaran is an executive with 30 years of leadership experience forged from a career spent operating in global markets in high-growth entrepreneurial companies and blue-chip multi-nationals, including PwC, Kraft Foods, Novell Inc. and Northern Foods.
Ciaran has also played a leadership role in advocating for safe, ethical high-quality research through his 2014 Chairmanship of the Association of Clinical Research Organisations (ACRO). ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. In 2014 Ciaran was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the biopharma industry.
Ciaran graduated with a Bachelor of Commerce degree from University College Dublin and he is a Fellow of the Institute of Chartered Accountants in Ireland. He was awarded an Honorary Degree of Doctor of Laws from University College Dublin in 2013 for his support of third level research & innovation in Ireland.
Chief Executive Officer, ICON plc
Expertise: The Global Clinical Research Market
Dr. Steve Cutler was appointed Chief Executive Officer of ICON in March, 2017. Steve has over 23 years’ experience within the pharmaceutical and CRO industry and joined ICON from Kendle where he held the position of Chief Executive Officer, having previously served as Kendle’s Chief Operating Officer. Prior to Kendle, Steve spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Steve held positions with Sandoz (now Novartis) in Australia and Europe.
Chief Information Officer
Prior to this he held the position of Global Head of Data Management at ICON Clinical Research. He joined the company in Feb-2001 as Manager of Data management in Dublin. He subsequently went on to set-up ICON's process improvement initiative "IMPROVE" and returned to Data Management to become EU VP of Data Management before becoming Global Head of Data Management in 2006.
Expertise: Resourcing for Clinical Trials
Colin Stanley is President of DOCS. He has over 14 years of experience working in the CRO industry. He joined ICON as a Project Manager in 2001 and has since held a range of positions of increasing responsibility. Since January 2011 Colin held the position of Chief Operating Offer for DOCS returning from Asia where he was Vice President of Clinical Operations, Asia Pacific with responsibility for all projects and staff in the region. Previous to this he was Director of Clinical Operations based in the US and in 2005 he led IMPROVE, a global Initiative focused on process improvement across all aspects of ICON’s business. He has also held various positions in Data Management including Head of Data Management, Europe. Colin started his career in Data Management at Quintiles.